MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk
A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered by researchers at Boston Children’s Hospital, permits rapid construction of new vaccines that activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with a lower risk of adverse effects.
As reported by Fan Zhang, PhD, Ying-Jie Lu, PhD, and Richard Malley, MD, from Boston Children’s Division of Infectious Disease, in the Proceedings of the National Academy of Sciences on July 29, the method could speed development of new vaccines for a range of globally serious pathogens, or infectious agents.
Broadly speaking, the vaccines available today fall into two categories: whole-cell vaccines, which rely on weakened or killed bacteria or viruses; and acellular or subunit vaccines, which include a limited number of antigens—portions of a pathogen that trigger an immune response. Both approaches have advantages and disadvantages.
“Whole-cell vaccines elicit a broad range of immune responses, often just as an infection would, but can cause side effects and are hard to standardize,” said Malley. “Acellular vaccines can provide good early immunity with less risk of side effects, but the immune responses they induce wane with time.”
The MAPS method may allow vaccine developers to take a middle ground, where they can link multiple protein and polysaccharide (sugar) antigens from one or more pathogens together in a modular fashion, much as one would connect Lego blocks.
The resulting complex—which resembles a scaffold of polysaccharides studded with proteins—can stimulate both antibody and T-cell responses simultaneously much like whole-cell vaccines, resulting in stronger immunity to the source pathogen(s). However, because the composition of a MAPS vaccine is well defined and based on the use of isolated antigens (as one would find with an acellular vaccine) the risk of side effects should be greatly reduced.
For instance, mice injected with a MAPS vaccine combining proteins from tuberculosis (TB) and polysaccharides from Streptococcus pneumoniae (pneumococcus) mounted vigorous antibody and T-cell responses against TB, whereas those vaccinated with TB protein antigens alone mounted only an antibody response.
Similarly, 90 percent of mice given a MAPS-based vaccine containing multiple pneumococcal polysaccharide and protein antigens were protected from a lethal pneumococcus infection, mounting strong antibody and T-cell responses against the bacteria. By contrast, 30 percent of mice vaccinated with the same antigens in an unbound state survived the same challenge.
“The MAPS technology gives you the advantages of: whole-cell vaccines while being much more deliberate about which antigens you include; doing it in a quantitative and precise way; and including a number of antigens so as to try to replicate the effectiveness of whole-cell vaccination,” Malley explained. “The immunogenicity of these constructs is greater than the sum of their parts, somewhat because they are presented to the host as particles.”
The system relies on the interactions of two compounds, biotin and rhizavidin, rather than covalent binding as is used in most of the current conjugate vaccines. To build a MAPS vaccine, biotin is bound to the polysaccharide(s) of choice and rhizavidin to the protein(s). The biotin and rhizavidin then bind together through an affinity interaction analogous to Velcro. The construction process is highly efficient, significantly reducing the time and cost of vaccine development and production.
The Latest Bing News on:
- Moderna starts testing HIV vaccine in humanson March 20, 2023 at 5:00 pm
“We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna's mRNA platform,” said Dr. Mark Feinberg, president and CEO of IAVI, in a statement.
- Inadequate sleep associated with lower vaccine-induced humoral immunityon March 19, 2023 at 6:18 pm
Vaccines continue to be the most effective option to mitigate the coronavirus disease 2019 (COVID-19) pandemic; however, simple behavioral interventions that may boost vaccine-induced humoral ...
- RSV Vaccines Are Nearly Here after Decades of False Startson March 19, 2023 at 5:00 pm
Decades of failed attempts have given way to several successful vaccines and treatments for the respiratory disease RSV ...
- Software Tool Makes Vaccine Development Faster and More Accurateon March 17, 2023 at 2:21 am
A new software tool developed by Texas Biomedical Research Institute and collaborators can help scientists and vaccine developers quickly edit genetic blueprints of pathogens to make them less harmful ...
- World’s first mRNA vaccine against deadly plague bacteria is 100% effectiveon March 16, 2023 at 5:30 am
Israeli researchers developed the world's first messenger mRNA-based single-dose vaccine that is 100 percent effective against the lethal plague bacteria.
- Web-based tool makes vaccine development faster and more accurateon March 15, 2023 at 12:06 pm
That is very helpful for vaccine design as well as basic research." Users tell CoDe which genetic sequence to deoptimize. The program identifies which specific nucleotides (letters) to change ...
- Scientists are working on a vaccine that could fight any SARS-CoV-2 strainon March 14, 2023 at 1:02 am
Scientists at the Massachusetts Institute of Technology (MIT) are working to develop a unique vaccine that could potentially counteract all variants of SARS-CoV-2.
- Could vaccines be a cure for antibiotic-resistant bacteria?on March 11, 2023 at 10:18 am
Israeli scientists announce 100% effectiveness of mRNA vaccine against Black Plague-causing bacteria in preclinical trial performed on mice.
- Creating a versatile vaccine to take on COVID-19 in its many guiseson March 10, 2023 at 6:43 am
One of the 12 labors of Hercules, according to ancient lore, was to destroy a nine-headed monster called the Hydra. The challenge was that when Hercules used his sword to chop off one of the monster's ...
- Did AI Just Help Us Discover a Universal COVID Vaccine?on March 9, 2023 at 9:35 am
Beast / ShutterstockThe world is continuing to learn how to live with COVID-19, but we’re still caught under the alarming specter of new variants. A single new strain with more ferocious infectivity ...
The Latest Google Headlines on:
[google_news title=”” keyword=”Vaccine design” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- Coronavirus Today: How immune are we?on March 21, 2023 at 10:30 am
When all mask mandates are gone, and social distancing is long forgotten, what will protect us from the coronavirus?
- COVID-19 in Maryland - DAILY UPDATES: Map, new case data, vaccine infoon March 19, 2023 at 5:00 pm
Submit food, cash, energy, emergency and aged/blind/disabled medical assistance applications online via the Department of Human Services website or the MyDHR portal. Medical Assistance ...
- A country-by-country guide to coronavirus vaccine booster planson March 17, 2023 at 7:19 pm
When does the rollout start? The fall, with those eligible being automatically invited based on their records from their insurance company and doctor. Which vaccines will be used? BioNTech/Pfizer or ...
- Maura Healey lifting COVID health emergency, vaccine mandateon March 17, 2023 at 4:47 pm
Some of the last vestiges of the COVID-19 emergency declaration will end in May when Gov. Maura Healey will lift the modified public health emergency and walk back a vaccine mandate for tens of ...
- Scientists create antibody 'cocktail' to fight deadly Lassa viruson March 15, 2023 at 5:00 pm
A group of researchers have used the Advanced Photon Source to look at monoclonal antibodies to subvert the “shield” of the Lassa virus, potentially paving the way for new therapies.
- World’s first plant-based COVID vaccine wins approvalon March 14, 2023 at 5:00 pm
Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...
- Only My Number card accepted to get smartphone vaccine passporton March 10, 2023 at 4:00 pm
Applicants for smartphone-based COVID-19 “vaccine passports” will have to present their My Number identification cards to confirm their identity, the Digital Agency said on Oct. 19 ...
- MTA lifts COVID vaccine requirement for new hireson March 10, 2023 at 2:36 pm
The new rule, allowing MTA employees to be hired regardless of their vaccination status, is to take effect Monday, according to an internal agency memo.
- In a First, an mRNA Vaccine for a Deadly Bacterium is Createdon March 10, 2023 at 8:29 am
While the world became very familiar with mRNA vaccines because of the COVID-19 pandemic, mRNA vaccines have been around for awhile. | Health And Medicine ...
- Researchers develop a 100%-effective mRNA vaccine for deadly bacteriaon March 9, 2023 at 9:44 am
For the first time in the world: a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a ...
The Latest Google Headlines on:
[google_news title=”” keyword=”MAPS-based vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]